President Joe Biden tests positive for COVID-19; Amazon will acquire One Medical for $18 per share, totaling roughly $3.9 billion; the Biden administration is elevating a division of HHS to improve pandemic responses.
President Joe Biden tested positive for COVID-19 and is experiencing very mild symptoms, the White House announced in a press release. The positive test comes days after his return from a trip to the Middle East, where he was in close contact with a number of leaders. The White House noted that Biden is fully vaccinated and has received 2 booster doses, and has already begun taking Paxlovid. Until he tests negative for the virus, he will continue to work in isolation at the White House.
Amazon and One Medical reached a definitive merger agreement where Amazon will acquire the primary health care provider, the companies announced in a press release. Under the all-cash deal, Amazon will acquire One Medical for $18 per share, for a total of roughly $3.9 billion. According to Neil Lindsay, senior vice president of Amazon Health Services, this acquisition will improve the health care experience by making it more accessible, noting that health care is in need of reinvention.
The Biden administration is developing a division of HHS to oversee US responses to pandemic threats and other health emergencies, The New York Times reported. This move will take the existing office of the Assistant Secretary for Preparedness and Response and promote it to its own operating division, the Administration for Strategic Preparedness and Response. This elevated division will effectively create a new federal agency to serve as a counterpart to the CDC, FDA, and National Institutes of Health to oversee the country’s emergency medical stockpile and the distribution of emergency vaccines.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen